Immune-biochemical interactions in schizophrenia

Schizophrenia Research

Volumn 44, Issue 3, 2000, Pages 245-246

  Taylor, K ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTICOAGULANT AGENT; FATTY ACID; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LIPOCORTIN 5; PHOSPHOLIPASE A2; PHOSPHOLIPID;

BRAIN DEVELOPMENT; CELL DAMAGE; ENVIRONMENTAL FACTOR; FAT INTAKE; GENETIC DISORDER; HUMAN; IMMUNITY; INFLUENZA; LETTER; PRENATAL EXPOSURE; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA;

EID: 0034283754     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(99)00194-2     Document Type: Article

References (15)

1. J.V. Bonventre Z. Huang M.R.O Taheri E. Leary E. Li M.A. Moskowitz A. Sapirstein Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2 Nature 390 1997 622 625
2. E. Franzek H. Beckmann Schizophrenia and birth seasonality — contrary results in relation to genetic risk Fortschr. Neurol. Psychiatr. 61 1993 22 26
3. W.F. Gattaz C.V. Hubner T.J. Nevalainen T. Thuren P.K. Kinnunen Increased serum phospholipase A2 activity in schizophrenia: a replication study Biol. Psychiatry 28 1990 495 501
4. N. Gordon Nutrition and cognitive function Brain Dev. 19 1997 165 170
5. R.T. Huang B. Lichtenberg O. Rick Involvement of annexin V in the entry of influenza viruses and role of phospholipids in infection FEBS Lett. 392 1996 59 62
6. J. Kaburaki M. Kuwana M. Yamamoto S. Kawai Y. Ikeda Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus Am. J. Hematol. 54 1997 209 213
7. P. Klivenyi M.F. Beal R.J. Ferrante O.A. Andreassen M. Wermer M.R. Chin J.V. Bonventre Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity J. Neurochem. 71 1998 2634 2637
8. G. Kurtz N. Mueller The antiphospholipid syndrome and psychosis Am. J. Psychiatry 151 1994 1841 1842
9. J.P. Mira T. Dubois J.P. Oudinet S. Lukowski F. Russo Marie B. Geny Inhibition of cytosolic phospholipase A2 by annexin V in differentiated permeabilized HL-60 cells. Evidence of crucial importance of domain I type II Ca2+-binding site in the mechanism of inhibition J. Biol. Chem. 272 1997 10474 10482
10. T. Nishizaki T. Nomura T. Matsuoka Y. Tsujishita Arachidonic acid as a messenger for the expression of long-term potentiation Biochem. Biophys. Res. Commun. 254 1999 446 449
11. J.H. Rand X.X. Wu S. Guller J. Scher H.A. Andree C.J. Lockwood Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi Am. J. Obstet. Gynecol. 177 1997 918 923
12. J.R. Smythies Oxidative reactions and schizophrenia: a review-discussion Schizophr. Res. 24 1997 357 364
13. H. Speijer S.W. Jans C.P. Reutelingsperger C.E. Hack G.J. van der Vusse W.T. Hermens Partial coverage of phospholipid model membranes with annexin V may completely inhibit their degradation by phospholipase A2 FEBS Lett. 402 1997 193 197
14. E.F. Torrey A.E. Bowler R. Rawlings A. Terrazas Seasonality of schizophrenia and stillbirths Schizophr. Bull. 19 1993 557 562
15. P. Wright N. Takei L. Rifkin R.M. Murray Maternal influenza, obstetric complications, and schizophrenia Am. J. Psychiatry 152 1995 1714 1720